Delcath Systems
Ny, US
Biotech
Founders & leadership
RS
Roger StollDirector
BK
Barbra KeckExecutive Officer
JS
Jennifer SimpsonExecutive Officer, Director
WR
William RueckertDirector
MT
Marco TagliettiDirector
Reported raises · per SEC filings
Form D private placements$7MraisedMar 2024 · 17 investors · Biotechnology
Rule 506(b)$25MraisedMar 2023 · 17 investors · Biotechnology
Rule 506(b)$3.8MraisedDec 2022 · 7 investors · Biotechnology
Rule 506(b)$5MraisedJul 2022 · 6 investors · Biotechnology
Rule 506(b)$9.5MraisedAug 2019 · 33 investors · Biotechnology
Rule 506(b)$20MraisedJul 2019 · 31 investors · Biotechnology
Rule 506(b)$1.6MraisedAug 2018 · 1 investors · Biotechnology
Rule 506(c)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.